Innovation in Ireland →
VP of Venture Capital, Pfizer Inc.
Professor of Innovation at The University of Texas at Austin
CEO and Founder, Techstars
Co-Founder, VP of Technology, Entropic Communications
CEO and Fund Manager, Renaissance Venture Capital Fund
Managing Director, D.E. Shaw and Co., L.P.
VP of Research & Policy, Ewing Marion Kauffman Foundation
Founder, Gilt Groupe
Concert Pharmaceuticals makes deuterium-modified pharmaceutical products.
Boston · 03/11/15
1:00 - 5:00 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.